Abstract:Background: The availability of central nervous system stimulants has risen in recent years, along with increased dispensing of stimulants for treatment of, for example, parent-reported attention-deficit/hyperactivity disorder in children and new diagnoses during adulthood. Typologies of drug use, as has been done with opioids, fail to include a sufficient range of behavioral factors to contextualize person-centric circumstances surrounding drug use. Understanding these patterns across drug classes would bring public health and regulatory practices toward precision public health. Objective: The objective of this study was to quantitatively delineate the unique behavioral profiles of adults who currently nonmedically use stimulants and opioids using a latent class analysis and to contrast the differences in findings by class. We further evaluated whether the subgroups identified were associated with an increased Drug Abuse Screening Test-10 (DAST-10) score, which is an indicator of average problematic drug use. Methods: This study used a national cross-sectional web-based survey, using 3 survey launches from 2019 to 2020 (before the COVID-19 pandemic). Data from adults who reported nonmedical use of prescription stimulants (n=2083) or prescription opioids (n=6127) in the last 12 months were analyzed. A weighted latent class analysis was used to identify the patterns of use. Drug types, motivations, and behaviors were factors in the model, which characterized unique classes of behavior. Results: Five stimulant nonmedical use classes were identified: amphetamine self-medication, network-sourced stimulant for alertness, nonamphetamine performance use, recreational use, and nondiscriminatory behaviors. The drug used nonmedically, acquisition through a friend or family member, and use to get high were strong differentiators among the stimulant classes. The latter 4 classes had significantly higher DAST-10 scores than amphetamine self-medication (P<.001). In addition, 4 opioid nonmedical use classes were identified: moderate pain with low mental health burden, high pain with higher mental health burden, risky behaviors with diverse motivations, and nondiscriminatory behaviors. There was a progressive and significant increase in DAST-10 scores across classes (P<.001). The potency of the opioid, pain history, the routes of administration, and psychoactive effect behaviors were strong differentiators among the opioid classes. Conclusions: A more precise understanding of how behaviors tend to co-occur would improve efficacy and efficiency in developing interventions and supporting the overall health of those who use drugs, and it would improve communication with, and connection to, those at risk for severe drug outcomes.

Associations among drug acquisition and use behaviors, psychosocial attributes, and opioid-involved overdoses

Associations among Drug Acquisition and Use Behaviors, Psychosocial Attributes, and Opioid-Involved Overdoses: A SEM Analysis

Poly-victimization and opioid use during late adolescence and young adulthood: Health behavior disparities and protective factors.

The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study

Agent-based Dynamics of a SPAHR Opioid Model on Social Network Structures

Association Between Self-Reported Opioid Use and Behavioral/Social Health Characteristics—Arizona, 2020

Understanding the factors driving the opioid epidemic using machine learning

Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs

Number of opioid overdoses and depression as a predictor of suicidal thoughts

Measuring Network Dynamics of Opioid Overdose Deaths in the United States

Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study

Demographic, Social, Behavioral, and Clinical Characteristics Associated with Long-Term Opioid Therapy and Any Opioid Prescription in High-Risk VA Patients

Investigating the importance of social vulnerability in opioid-related mortality across the United States

Genetic and non-genetic predictors of risk for opioid dependence

Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose

Immediate and Neighborhood Contextual Effects on Intentional, Accidental, and Fatal Drug Overdoses in a Non-Urban Jurisdiction

Incidence, Timing and Social Correlates of the Development of Opioid Use Disorder Among Clients Seeking Treatment for an Alcohol Use Problem: Changes Over the Three Waves of the Opioid Epidemic

Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis

Discovering Opioid Use Patterns From Social Media for Relapse Prevention

Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for intervention

Association of genetic variants in CYP3A5, DRD2 and NK1R with opioid overdose